Summary:
- The article discusses the latest developments in the COVID-19 vaccine landscape, focusing on progress in Europe and challenges in the United States.
- It highlights the exciting news from Europe, where a new generation of COVID-19 vaccines is being developed and tested, offering potential improvements over the current vaccines.
- The article also outlines the roadblocks and challenges faced in the United States, where the development and deployment of these next-generation vaccines have been slower and more challenging.